AlphaFold predicted structure
PSMB9 · P28065

Mean pLDDT
90.9/ 100
Very high
219 residues
Confidence breakdown
- Very high(≥ 90)85%
- Confident(70–90)6%
- Low(50–70)3%
- Very low(< 50)6%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
proteasome 20S subunit beta 9
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Autoinflammatory disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownChildhood interstitial lung disease
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedCOVID-19 research
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownPrimary immunodeficiency or monogenic inflammatory bowel disease
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedplasma cell myeloma
MHC class I deficiency
proteasome-associated autoinflammatory syndrome 6
mantle cell lymphoma
proteasome-associated autoinflammatory syndrome 3
neoplasm
amyloidosis
Immunodeficiency by defective expression of HLA class 1
AL amyloidosis
acute lymphoblastic leukemia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Proteasome subunit beta type-9
The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH (PubMed:33727065, PubMed:34819510). The proteasome has an ATP-dependent proteolytic activity. This subunit is involved in antigen processing to generate class I binding peptides. Replacement of PSMB6 by PSMB9 increases the capacity of the immunoproteasome to cleave model peptides after hydrophobic and basic residues
Curated MONDO disease pages that list PSMB9 among their top associated genes.
PSMB9 · P28065

Mean pLDDT
90.9/ 100
Very high
219 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0